Artu Biologicals clinical trials
Acquired by ALK-Abelló A/S
The registry lists 3 studies whose lead sponsor is Artu Biologicals. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 5, 2010.
Status
- Completed
- 2
- Status unknown
- 1
Registry sponsor names on this page
- Artu Biologicals3 studies
Something wrong with this grouping? Tell us on the ALK-Abelló A/S page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All ALK-Abelló A/S studies →
- Efficacy and Safety of Grass Pollen Sublingual ImmunotherapyCompletedNCT00567346Phase 2/3
Sponsor listed in the registry: Artu Biologicals · Artu Biologicals — acquired company within the ALK-Abelló A/S group
- Long-term Efficacy and Safety Study With Oralgen Grass PollenCompletedNCT00824447Phase 2/3
Sponsor listed in the registry: Artu Biologicals · Artu Biologicals — acquired company within the ALK-Abelló A/S group
- A Randomised, Double-blind, Placebo Controlled Study With Oralgen Grass Pollen RhinoconjunctivitisStatus unknownNCT00812799Phase 3
Sponsor listed in the registry: Artu Biologicals · Artu Biologicals — acquired company within the ALK-Abelló A/S group